The production volumes of chemical and pharmaceutical products in Denmark have seen varied trends over the past decade. The market displayed robust growth from 2013 to 2019, with occasional fluctuations, peaking at over 160 Billion Danish Krones in 2019. The year 2020 witnessed a significant decline of -14.57% year-on-year, likely due to global disruptions. However, the sector rebounded in 2021 with a dramatic increase of 36.23% year-on-year, reaching 186.32 Billion Danish Krones. The subsequent years saw moderate adjustments, with the sector stabilizing at 178.31 Billion Danish Krones in 2023. The 5-year Compound Annual Growth Rate (CAGR) up to 2023 stands at 2.58%.
Forecast for the upcoming years suggests steady growth, with a moderate 5-year forecasted CAGR of 1.88%. By 2028, production volumes are expected to reach over 202 Billion Danish Krones, representing a 9.78% growth from 2023 levels.
Future trends to watch for include technological advancements in pharmaceutical manufacturing, potential regulatory changes, and global economic impacts that could influence production volumes. Continuous investments in research and development, along with potential shifts in demand for new treatments and chemical products, will be critical in driving future growth within this sector.
